Related Experiment Video
Updated: Sep 24, 2025
11:10
Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
16.4K
[Pilots with diabetes mellitus: cleared for take-off?]
E M W Eekhoff1,2, Erik Serné1, Harold W de Valk3
1Amsterdam UMC, afd. Interne Geneeskunde, Amsterdam.
Nederlands Tijdschrift Voor Geneeskunde
|May 2, 2022
Summary
People with insulin-dependent diabetes can work in many transport roles in the Netherlands. Adopting the UK's "pilot-diabetes" protocol could allow pilots with diabetes to fly safely.
Area of Science:
- Occupational health
- Endocrinology
- Transportation safety
Background:
- Advances in diabetes management and monitoring have improved safety for individuals with insulin-dependent diabetes.
- Existing protocols in countries like the UK permit pilots with type 1 and type 2 diabetes mellitus to fly under specific conditions.
- The Netherlands currently permits individuals with insulin-dependent diabetes in various transport roles but not as pilots.
Purpose of the Study:
- To assess the feasibility and safety of allowing pilots with insulin-dependent diabetes to operate aircraft in the Netherlands.
- To compare current Dutch regulations for diabetic professionals in transport with international standards, particularly the UK's pilot protocol.
Main Methods:
- Review of developments in modern diabetes care, including innovative monitoring techniques.
- Analysis of existing protocols for pilots with diabetes in the UK and other European countries.
- Evaluation of the suitability of these protocols for the Dutch context across various transport professions.
Main Results:
- Individuals with insulin-dependent diabetes can currently work as train, ship, tram, metro, and bus transporters in the Netherlands.
- A significant gap exists as pilots with diabetes are not permitted to fly professionally in the Netherlands, unlike in some other nations.
- Current diabetes care, monitoring, and medical supervision support safe professional operation in other transport sectors.
Conclusions:
- It is a responsible and advantageous step to introduce the UK's "pilot-diabetes" protocol in the Netherlands.
- Implementing this protocol would align the Netherlands with international standards and expand professional opportunities for pilots with diabetes.
- Sufficient data and strong arguments support the safe integration of pilots with insulin-dependent diabetes into the aviation sector.
Related Concept Videos
01:15Diabetes: Symptoms, Diagnosis, and Complications
752
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
752
01:22Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
01:22Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
01:15Diabetes: Management and Pharmacotherapy
422
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
422
01:20Pathophysiology of Diabetes
1.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.3K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
318
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
318